AvertD Test for First-Time Opioid Users
Part of Mental health clinical trials.
This study is testing a new tool called AvertD that helps doctors see if a patient might be at higher risk of developing opioid use disorder before they get their first opioid painkiller prescription. If you are getting your first opioid prescription for 4 to 30 days, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are about to receive your first-ever opioid prescription (for pain).
- Your prescription will be for 4 to 30 days.
- You are willing to take the AvertD test as part of your care.
- You can commit to yearly follow-up assessments for 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study evaluates a new digital toolkit designed to help identify and support people experiencing intimate partner violence (abuse by a romantic partner). If you receive opioid treatment, this research aims to make it easier for your care team to recognize and help address violence in your relationships.
This trial tests a flexible, personalized approach to treating opioid use disorder (OUD) that adjusts over time based on how you're doing. It aims to find the best treatment plan to help you recover and stay healthy.
This trial tests if a computer tool can help doctors prescribe medications for opioid use disorder during regular checkups. It may be right for you if you take prescription opioids for pain or have had issues with opioids.
This study tests a clinical decision support tool to help doctors safely reduce opioid doses in patients who have been on opioids for a long time. It may be a good fit if you or someone you care for is slowly lowering their opioid dose under a doctor's care.
This study tests whether a computer program can help doctors and patients have a conversation about safe opioid use. It uses information from your medical records to send reminders to your doctor, aiming to prevent overdoses.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.